treatment

PRRT offers longer progression free survival
news

New results from the NETTER-1 study that compared Sandostatin LAR 60mg versus treatment with the novel peptide receptor radionuclide therapy (PRRT) Lutathera have been made available. These findings, released at the 2015 European Cancer Congress, show that for patients living with unresectable mid-gut neuroendocrine cancers that PRRT provided a longer progression free survival than with just long-acting somastatin analogues alone. Read more about the findings of this study.

For many patients dealing with a neuroendocrine cancer diagnosis, the cost of paying for insurance premiums, deductibles, total out of pocket expenses and other miscellaneous expenses can be overwhelming. Here are a few resources to help you afford the care and treatment you deserve. Angel Flights This organization pairs patients with volunteers pilots to help patients travel for the care they need. Good Days Foundation This foundation works closely with

Neuroendocrine tumors have a variety of treatments available. From surgical, radiologic and medical management, there are a number of treatment options. No two patients are exactly alike and throughout the course of the disease, all options should be considered. Here is a brief overview of treatment modalities.  SURGICAL OPTIONS Surgery is always the number one treatment of all neuroendocrine tumors including carcinoid if the patient is a surgical candidate. It

Video presentation of Nancy Teixeira from Wren Labs on May 18, 2014
video

[embedplusvideo height=”400″ width=”584″ editlink=”http://bit.ly/Txp2YA” standard=”http://www.youtube.com/v/0YfLOUS61pg?fs=1″ vars=”ytid=0YfLOUS61pg&width=584&height=400&start=&stop=&rs=w&hd=0&autoplay=0&react=1&chapters=&notes=” id=”ep1361″ /] On May 18th, 2014, Nancy Teixeira, administrator from Wren Labs, talked to Northwoods NETS to talk about their unique biomarker that helps detect neuroendocrine cells in the blood sooner than any other biomarker including Chromagranin A (CGA) or pancreastatin. Nancy is both a RN and a Carcinoid patient, so she is very knowledgeable about the disease. Download the Wren Labs Powerpoint Presentation –

Dr. Vargas presents to Northwoods NETS
website

On Sunday, March 9th, 2014, the Neuroendocrine Tumor Program team of Nebraska Medical Center presented their multidisciplinary approach to Northwoods NETS. Dr. Luciano Vargas gave a very informative speech that was a good primer about neuroendocrine tumors in general, as well as how their center approaches this disease. [embedplusvideo height=”450″ width=”584″ editlink=”http://bit.ly/1kkv8no” standard=”http://www.youtube.com/v/Orlery1YSV4?fs=1″ vars=”ytid=Orlery1YSV4&width=584&height=450&start=&stop=&rs=w&hd=0&autoplay=0&react=1&chapters=&notes=” id=”ep4986″ /]